Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 15 (1999), Issue 1-3, Pages 159-165
http://dx.doi.org/10.1155/1999/748254

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe

P. J. Morrison,1 C. M. Steel,2 H. F. A. Vasen,3 D. Eccles,4 D. G. R. Evans,5 P. Møller,6 S. Hodgson,7 D. Stoppa-Lyonnet,8 J. Chang-Claude,9 M. Caligo,10 E. Olah,11 N. E. Haites,12 and N. C. Nevin1

1Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK
2School of Biomedical Sciences, University of St. Andrews, Scotland, UK
3Foundation for the Detection of Hereditary Tumours, c/o University Hospital, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands
4Department of Human Genetics, Princess Ann Hospital, Southampton SO16 5YA, UK
5Department of Medical Genetics, St Mary’s Hospital, Manchester, UK
6Unit of Medical Genetics, The Norwegian Radium Hospital, N-0310 Oslo, Norway
7Division of Medical and Molecular Genetics, Guy’s Hospital, London Bridge, London SE1 9RT, UK
8Unité de Génétique Oncologique Institut Curie - Section Médicale 26, rue d’Ulm 75231 Paris Cedex 05, France
9Division of Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
10Institute of Pathology, University of Pisa, via Roma, 57, 56126 Pisa, Italy
11Department of Molecular Biology, National Institute of Oncology, H-1525 Budapest, Hungary
12Department of Medicine and Therapeutics (Medical Genetics), University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK

Received 9 December 1999; Accepted 9 December 1999

Copyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

P. J. Morrison, C. M. Steel, H. F. A. Vasen, et al., “Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe,” Disease Markers, vol. 15, no. 1-3, pp. 159-165, 1999. doi:10.1155/1999/748254